RBC Europe’s Denali Therapeutics DNLI Stock Holding History

RBC Europe’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-450	Closed	-$22.7K	–	755
2021 Q3	$22.7K	Sell	450 -50	-10%	-$2.82K	﹤0.01%	754
2021 Q2	$39.2K	Hold	500	–	–	﹤0.01%	647
2021 Q1	$28.6K	Hold	500	–	–	﹤0.01%	678
2020 Q4	$41.9K	Hold	500	–	–	﹤0.01%	562
2020 Q3	$17.9K	Hold	500	–	–	﹤0.01%	665
2020 Q2	$12.1K	Hold	500	–	–	﹤0.01%	729
2020 Q1	$8.76K	Hold	500	–	–	﹤0.01%	740
2019 Q4	$8.71K	Hold	500	–	–	﹤0.01%	824
2019 Q3	$7.66K	Sell	500 -215	-30%	-$4.11K	﹤0.01%	836
2019 Q2	$14.8K	Hold	715	–	–	﹤0.01%	716
2019 Q1	$16.6K	Buy	715 +615	+615%	+$12.9K	﹤0.01%	699
2018 Q4	$2.07K	Hold	100	–	–	﹤0.01%	1000
2018 Q3	$2.17K	Hold	100	–	–	﹤0.01%	1043
2018 Q2	$1.52K	Buy	+100	New	+$1.88K	﹤0.01%	1066

Other funds holding DNLI

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Temasek Holdings

Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return